PDOs were derived from ascites drainage samples from four patients with GCPM. Ascites drainage was filtered with a 70-um cell strainer then centrifuged at 300 g for 5 min. Pellets were resuspended into single-cell suspensions with PBS and incubated with red blood cell lysis buffer for 5 min on ice, then centrifuged again at 300 g for 5 min. Finally, the cells were embedded in Matrigel, seeded onto pre-warmed 24-well culture plates, and cultured in Advanced DMEM/F12 medium (GIBICO) with 50% L-WRN conditioned medium supplemented with 10 mM HEPES (GIBICO), 10 mM Nicotinamide (Sigma), 1X N2 (GIBICO), 1X B27 (GIBICO), 1X Glutamax (GIBICO), 1.25 mM N-Acetylcysteine (Sigma-Aldrich), 50 ng/mL EGF (Peprotech), 200 ng/mL FGF10 (Peprotech), 10 nM gastrin (R&D Systems), and 1X Primocin (Invivogen). 10 uM ROCK inhibitor (Y-27632, R&D Systems) was provided for the first generation of PDOs to prevent anoikis. PDOs were overlaid with culture medium and incubated at 37 °C in humidified air containing 5% CO2. Culture medium was changed every 3 days. For passaging, PDOs were collected by mechanically dissociating the Matrigel, centrifuged at 150 g for 5 min, incubated with pre-warmed TrypLE express for 7 min, then pipetted about 100 times. All PDOs were trypsinized to single cells under a light microscope then transferred into new matrigel with culture medium and plated in pre-warmed 24 well-plates, incubated at 37 °C in humidified air containing 5% CO2. PDOs were passaged every 7 days until at least the 15th generation. PDOs were treated with culture media and inhibitors including Hydroxychloroquine Sulfate (1uM), DC661 (4uM), TORIN1 (2uM), or Rapamycin (400 nM) for 7 days before analysis. Culture medium and drugs were changed every 3 days. To embed PDOs, culture media was removed, PDOs were washed in DPBS on ice for 15 mins, then PDOs were fixed in 10% formalin on ice for 2 h. Finally, PDOs were moved to 75% ethanol at 4 °C overnight, mounted in 3% agar, and embedded in paraffin.
Huang X.Z., Pang M.J., Li J.Y., Chen H.Y., Sun J.X., Song Y.X., Ni H.J., Ye S.Y., Bai S., Li T.H., Wang X.Y., Lu J.Y., Yang J.J., Sun X., Mills J.C., Miao Z.F, & Wang Z.N. (2023). Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis. Nature Communications, 14, 822.